A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgeries
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- 12 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Oct 2015 Status changed from recruiting to active, no longer recruiting according to the ClinicalTrials.gov record.
- 01 May 2015 New trial record